K-numberK242941
Device nameCO2 Laser Therapy Systems (SHE-LSP003-1)
ApplicantBeijing Sano Laser S&T Development Co.,Ltd
Product codeGEX
Device classClass II
Decision dateJan 27, 2025
DecisionSubstantially Equivalent
Regulation878.4810
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The CO2 Laser Therapy Systems (SHE-LSP003-1) is a laser surgical instrument used for body soft tissue ablation, vaporization, excision, and coagulation in dermatology, plastic surgery, and general surgery. It uses monochromatic CO2 laser light with strong penetration and precise focusing; when a continuous or pulsed laser beam irradiates biological tissue, the instantaneous high temperature causes photo-induced solidification and vaporization.

Technological characteristics

In normal mode, the device matches predicate K161925 in wavelength, laser type, laser classification, pulse width range, and frequency. In fractional mode, the device's parameters (density/spot range, pulse energy, spot size) fall within the range of predicate K241670, with a minor difference in pulse width range (0.1–9.9 ms versus 0.1–2.6 ms). The device operates at a fixed interval time of 1 ms regardless of emission frequency.

Test standards cited

IEC 60601-1 (general medical device safety), IEC 60601-1-2 (electromagnetic compatibility), IEC 60601-2-22 (surgical laser equipment), IEC/TR 60601-4-2 (electromagnetic immunity guidance), IEC 60825-1 (laser product safety and classification), ISO 10993-5 (in vitro cytotoxicity), ISO 10993-10 (irritation and hypersensitivity), and ISO 10993-23 (irritation tests).

Substantial equivalence argument

The applicant demonstrated substantial equivalence by showing the device meets identical technical specifications as K161925 in normal mode and operates within the parameter ranges of K241670 in fractional mode. All nonclinical testing confirmed compliance with applicable safety and performance standards, and the minor pulse width range difference does not affect actual safety or effectiveness. No clinical study was required because the device's performance matched the legally marketed predicate devices.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →